Yogeeta Dosanjh

Director of Clinical Operations

With over 15 years of service, particularly within Primary Care, at Vancouver Coastal Health (VCH), she joins us after serving as VCH’s Director of Operations, Primary Care, for Richmond Community.

 

Her leadership has been impactful, notably through her role in the planning and implementation of the Richmond Primary Care Networks and the establishment of the first Urgent & Primary Care Center in Richmond. Her skilled approach has also been evident in her work on Team-Based Care within Primary Care Networks and the creation of the Primary Care Clinic at Foundry Richmond.

 

Yogeeta is a strong advocate for primary care and the need to better understand the challenges of primary care in providing proactive and patient centred care. She has established longstanding relationships with key partners, and values collaborative leadership in achieving quality care and better health outcomes.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below